Clinical trials are
going digital.

We'll make sure it's safe and sound.

Triall brings Web 3 technologies to medical research. We are creating a digital ecosystem of blockchain-integrated software solutions to secure and streamline the global transition towards digital, decentralized clinical trials.

Our blockchain infrastructure makes clinical trial data tamper-resistant. It also enables secure and efficient integrations between the many isolated systems and parties involved in clinical trial processes.

Our software is created with clinical trial professionals to ensure optimal user experience, solving actual industry pain points.

Pharma Companies

develop new vaccines and therapeutics. They have to prove that these are safe and effective for humans.

Service Providers

such as Contract Research Organizations (CROs) and software providers are hired to manage clinical trials, in which safety and efficacy data are collected.

Hospitals

are selected as investigative sites. This is where doctors and nurses typically perform the research activities.

Patients

or healthy volunteers are recruited by hospitals to participate in clinical trials, after giving their informed consent.

What's the problem?

Clinical trials involve increasing amounts of electronic systems and data. It leads to a lack of oversight, and uncertainty about the integrity and authenticity of collected data. Such reduces efficiency and reliability in the development of new medicines.

How are we solving it?

Triall uses world-class blockchain and Self-Sovereign Identity (SSI) technologies to secure clinical trial data and promote system interoperability. Our software improves efficiency, quality, trust, and regulatory compliance for all parties involved.
Video

Why Triall?
View our animated explainer

From Triall HQ

Meet several
of our co-founders

Featured Partnership

Triall joins forces
with LTO Network

Development

Triall and Sphereon win gov't grant for SSI technology

Triall in 6 highlights

Deep Industry Experience

Combined, our team has managed 100+ clinical trials across 30+ countries, and successfully grown companies both in the Life Sciences and Software/Blockchain-as-a-Service industries.

Thought Leaders

Our team has published 250+ peer-reviewed papers on innovation in medical research, featured in top-tier scientific journals such as Nature and Science.

Global Partner & Customer Network

Years of industry operations have gained us a strong value network of partners and potential customers. It allows us to effectively bring our solutions to market.

Double-Digit Growth

Our target market is characterized by rapid digitalization, decentralization, and double-digit growth (CAGR of 13.8%). High upside is projected for those that can underpin this emerging digital ecosystem. Our solutions are specifically designed to do so.

Working Products

Our products have been used in over 7,000 clinical trials and by thousands of research professionals across the globe. Our blockchain-integrated document management solution, was credited as the world’s first implementation of blockchain in a live clinical trial (July 2019).

Market Validation

Leading stakeholders in our customer domain have expressed interest in our blockchain innovations, which directly respond to actual customer pain points.

Recent Coverage of Triall

Triall Platform

An end-to-end eClinical platform, offering the latest in mobile and decentralized technologies

Triall Platform

An end-to-end eClinical platform, offering the
latest in mobile and decentralized technologies

Advisory Board

Used in over 7,000 clinical trials globally, the Triall Platform consists of a suite of modular but complementary clinical trial software applications (‘eClinical solutions’) that support clinical trial professionals ‘end-to-end’—from trial start-up to close-out and post-study activities.

Built with modern trial designs in mind, the platform offers advanced web-based, mobile, and wearable integration capabilities to facilitate remote data collection from anywhere, anytime.

Triall’s eClinical solutions advance the state of the art in clinical trials by applying blockchain technology where it truly adds value—promoting data integrity, interoperability, and peer-to-peer exchange of medical data in a secure, efficient, and auditable way.

The underlying blockchain innovations have been validated with a Seal of Excellence by industry experts of the European Commission’s Horizon2020 program for Top research and innovation.

Platform solutions

  • Verial eTMFElectronic trial master file solution with blockchain proofs of data integrity
  • Triall EDCElectronic data capture solution with ePRO, eCOA, eSource & wearable integration modules
  • Triall CTMSIntegrated clinical trial management system
  • Triall RTSMRandomization and trial supply management solution
  • Atena PRMMulti-sided matchmaking platform for sponsors, CROs, investigators, participants
  • Blockchain MicroservicesFor verifiable proofs of data presence and integrity, and cross-system discovery, authentication, authorization, and exchange.
  • Research servicesSupporting study coordination and data management services.
  • Powered by:

Management team

  • Hadil Es-Sbai, MSc

    CEO

    Empathetic and tireless leader with extensive clinical development expertise. Innovator and team builder. Founder of multiple successful service companies in the Life Sciences.

  • Niels Klomp, MSc

    CTO

    Experienced blockchain and SaaS developer. Serial tech entrepreneur with 15+ years’ experience in various CTO roles. Director of the Factom Blockchain.

  • Joost Flach, PhD

    Head of Operations

    Clinical researcher, project manager and medical writer, operating at the interface between industry and academia. Early crypto enthusiast, dedicated to realizing end-user functionalities.

  • Arno Bisschop, MD, PhD

    Chief Medical Officer

    Medical doctor with 10yrs’ entrepreneurial experience as founder of healthcare and sustainability companies.

  • Linda van de Burgwal, PhD

    CFO

    Academic entrepreneur, project manager and consultant. Co-founder of two successful Life Sciences management consultancies. Holds a cum laude PhD in science commercialization.

  • Rob Posthumus, LL.M.

    General Counsel

    Corporate lawyer and deal-maker with extensive experience as legal counsel in the pharma & health care industries. Headed the legal department of Erasmus University Medical Center.

  • Raymond van der Waal, MSc

    Head of Marketing & BD

    Researcher, consultant, and copywriter with a background in Biomedical Sciences and Entrepreneurship. Passion for making complex technologies understandable for a broader audience.

  • Mark van der Waal, MSc

    Head of Innovation

    PhD candidate and consultant in medical innovation management with degrees in Health Technology Assessment and Management. Passionate designer with 14 years’ experience in UI / UX projects.

  • Sina DjaliHead of Integrated Data Analytics
    Janssen Pharmaceuticals (J&J)
    View on LinkedIn
  • Danielle BradburyVP Quality Assurance
    Galera Therapeutics
    View on LinkedIn
  • Prof. Niels Chavannes, MD, PhDHead of Research, Public Health & Primary Care Leiden University Medical Center
    View on LinkedIn
  • Cari Jacobs BlomDirector Quality & Compliance
    CR2O
    View on LinkedIn
  • Prof. Sjaak Bloem, PhDAssociate Director Behavioral Science
    Janssen Pharmaceuticals (J&J)
    View on LinkedIn
  • Allan BukuyaCOO
    TrialDocs International
    View on LinkedIn
  • Nick van den BulkHead Clinical Operations
    CR2O
    View on LinkedIn
  • Prof. Eric Claassen, PhDSequential Biotech Entrepreneur
    & Angel Investor Multiple ventures
    View on LinkedIn
  • Dustin PlantholtBlockchain & Crypto Expert
    Forbes | Bitcoin.com Podcast | Life's Though | Crypterns
    View on LinkedIn
  • Yassin MobarakBlockchain & Crypto Expert
    Dizer Capital
    View on LinkedIn
  • Maarten BoenderBlockchain & Crypto Expert
    Sphereon
    View on LinkedIn

Advisory Board

  • Sina DjaliHead of Integrated Data Analytics
    Janssen Pharmaceuticals (J&J)
    View on LinkedIn
  • Danielle BradburyVP Quality Assurance
    Galera Therapeutics
    View on LinkedIn
  • Prof. Niels Chavannes, MD, PhDHead of Research, Public Health & Primary Care Leiden University Medical Center
    View on LinkedIn
  • Cari Jacobs BlomDirector Quality & Compliance
    CR2O
    View on LinkedIn
  • Prof. Sjaak Bloem, PhDAssociate Director Behavioral Science
    Janssen Pharmaceuticals (J&J)
    View on LinkedIn
  • Allan BukuyaCOO
    TrialDocs International
    View on LinkedIn
  • Nick van den BulkHead Clinical Operations
    CR2O
    View on LinkedIn
  • Prof. Eric Claassen, PhDSequential Biotech Entrepreneur
    & Angel Investor Multiple ventures
    View on LinkedIn
  • Dustin PlantholtBlockchain & Crypto Expert
    Forbes | Bitcoin.com Podcast | Life's Though | Crypterns
    View on LinkedIn
  • Yassin MobarakBlockchain & Crypto Expert
    Dizer Capital
    View on LinkedIn
  • Maarten BoenderBlockchain & Crypto Expert
    Sphereon
    View on LinkedIn

Our blockchain-integrated software
is being used in real-world clinical trials today

paid for with TRL

Highlighted Trials

Active Trials:

Target disease

COVID-19

  • PhasePhase I
  • CountriesSA
  • Sites1 specialized vaccine unit
  • Participants45

Triall product used:

For document management and proof of data integrity

Target disease

Rift Valley Fever

  • PhasePhase I
  • CountriesBE
  • Sites1 specialized vaccine unit
  • Participants75

Triall product used:

For document management and proof of data integrity

Target disease

Irritable Bowel Syndrome

  • PhasePhase III
  • CountriesNL, UK, BE
  • Sites5 hospitals
  • Participants200+

Triall product used:

For document management and proof of data integrity

0
Clinical trials
0
Countries
0+
Research sites
0+
Patients / Participants

Excludes upcoming trials

Resources

Summary Deck

  • Version3.0
  • ReleasedApril 2022

Whitepaper

Major version update coming soon. See Summary Deck for up-to-date project representation.

Newsletter

Subscribe to the Triall Newsletter

Our newsletters provide a concise overview of project milestones, upcoming events, and anything else Triall-related.






Contact information

Office

Bisonspoor 3002 – C701 (Copenhagen Tower), 3605 LT Maarssen, The Netherlands

E-MAIL (GENERAL)

[email protected]

Press & Media

[email protected]

Chamber of Commerce (Amsterdam)

71656227

GDPR